Ground Swell Capital’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Ground Swell Capital’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1K	Buy	+240	New	+$1.48K	﹤0.01%	2368

Other funds holding NWBO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ground Swell Capital's NWBO Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2014: 240 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings.

71 funds tracked by Wall St. Rank hold NWBO as of Q3 2014.

Ground Swell Capital held 240 shares of Northwest Biotherapeutics, Inc. Common stock worth $1K as of Q3 2014.
Northwest Biotherapeutics, Inc. Common stock was a new Ground Swell Capital position in Q3 2014.
Northwest Biotherapeutics, Inc. Common stock made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2368 holding.
71 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.